American International Group’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-52,313
Closed -$3.57M 1943
2024
Q1
$3.57M Buy
52,313
+5,686
+12% +$394K 0.01% 841
2023
Q4
$2.93M Sell
46,627
-188
-0.4% -$9.76K 0.01% 883
2023
Q3
$2.39M Buy
46,815
+2,563
+6% +$126K 0.02% 904
2023
Q2
$2.21M Buy
44,252
+9,639
+28% +$457K 0.01% 942
2023
Q1
$1.3M Buy
34,613
+689
+2% +$29.2K 0.01% 1104
2022
Q4
$1.63M Buy
33,924
+8,353
+33% +$328K 0.01% 1009
2022
Q3
$614K Buy
25,571
+899
+4% +$22.8K ﹤0.01% 1450
2022
Q2
$537K Buy
24,672
+3,502
+17% +$81K ﹤0.01% 1555
2022
Q1
$511K Sell
21,170
-297
-1% -$6.49K ﹤0.01% 1706
2021
Q4
$511K Sell
21,467
-643
-3% -$15K ﹤0.01% 1796
2021
Q3
$561K Sell
22,110
-162
-0.7% -$3.93K ﹤0.01% 1770
2021
Q2
$501 Buy
22,272
+5,387
+32% +$110K ﹤0.01% 1923
2021
Q1
$333 Buy
16,885
+6,299
+60% +$159K ﹤0.01% 2070
2020
Q4
$281 Sell
10,586
-303
-3% -$11.3K ﹤0.01% 2089
2020
Q3
$538K Buy
+10,889
New +$434K ﹤0.01% 1560

Other funds holding PCVX

American International Group's PCVX Position: Q2 2024 in Review

American International Group sold out of Vaxcyte (PCVX) in Q2 2024, closing a stake of 52,313 shares — an estimated $3.57M sold.

American International Group first reported a position in PCVX in Q3 2020 and held it in 15 quarters. The position peaked at $3.57M in Q1 2024. 265 funds tracked by Wall St. Rank hold PCVX as of Q2 2024.

  • American International Group reported no remaining Vaxcyte position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 52,313 Vaxcyte shares in Q2 2024, an estimated $3.57M.
  • American International Group first reported a position in Vaxcyte in Q3 2020 and held it in 15 quarters.
  • American International Group's Vaxcyte position peaked at $3.57M in Q1 2024.
  • 265 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.